Tags

Type your tag names separated by a space and hit enter

The possible of immunotherapy for COVID-19: A systematic review.
Int Immunopharmacol. 2020 Jun; 83:106455.II

Abstract

The novel coronavirus (2019-nCoV) is an emerging pathogen that was first described in late December 2019 and causes a severe respiratory infection in humans. Since the outbreak of COVID-19, international attention has raised to develop treatment and control options such as types of immunotherapies. The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV. These methods include several types of vaccines, monoclonal antibody candidates, and etc. This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV. Web of Science (ISI), PubMed, and Scopus databases were used to search for suitable keywords such as 2019-nCoV, novel coronavirus, Immunotherapy, interleukin, vaccine and the related words for relevant publications up to 24.3.2020. The present systematic review was performed based on PRISMA protocol. Data extraction and quality valuation of articles were performed by two reviewers. 51 articles were the results of the search and based on the inclusions and exclusions criteria, 7 articles were included in the final review. As a conclusion of these studies demonstratedthat although no serious research has been done on this subject at the time of writing this article, similar studies on the related viruses showed notable results. So immunotherapy for this virus can also be a suitable option.

Authors+Show Affiliations

Cellular and Molecular Research Center, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran; Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran. Electronic address: sorayya.ghasemi@gmail.com.

Pub Type(s)

Journal Article
Systematic Review

Language

eng

PubMed ID

32272396

Citation

AminJafari, Akram, and Sorayya Ghasemi. "The Possible of Immunotherapy for COVID-19: a Systematic Review." International Immunopharmacology, vol. 83, 2020, p. 106455.
AminJafari A, Ghasemi S. The possible of immunotherapy for COVID-19: A systematic review. Int Immunopharmacol. 2020;83:106455.
AminJafari, A., & Ghasemi, S. (2020). The possible of immunotherapy for COVID-19: A systematic review. International Immunopharmacology, 83, 106455. https://doi.org/10.1016/j.intimp.2020.106455
AminJafari A, Ghasemi S. The Possible of Immunotherapy for COVID-19: a Systematic Review. Int Immunopharmacol. 2020;83:106455. PubMed PMID: 32272396.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The possible of immunotherapy for COVID-19: A systematic review. AU - AminJafari,Akram, AU - Ghasemi,Sorayya, Y1 - 2020/04/02/ PY - 2020/3/25/received PY - 2020/3/27/accepted PY - 2020/4/10/pubmed PY - 2020/5/30/medline PY - 2020/4/10/entrez KW - 2019-nCoV KW - COVID-19 KW - Immunotherapy KW - Interleukin KW - Monoclonal antibody KW - Vaccine SP - 106455 EP - 106455 JF - International immunopharmacology JO - Int Immunopharmacol VL - 83 N2 - The novel coronavirus (2019-nCoV) is an emerging pathogen that was first described in late December 2019 and causes a severe respiratory infection in humans. Since the outbreak of COVID-19, international attention has raised to develop treatment and control options such as types of immunotherapies. The immunotherapy is an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV. These methods include several types of vaccines, monoclonal antibody candidates, and etc. This systematic review article was designed to evaluate the existing evidence and experience related to immunotherapy for 2019-nCoV. Web of Science (ISI), PubMed, and Scopus databases were used to search for suitable keywords such as 2019-nCoV, novel coronavirus, Immunotherapy, interleukin, vaccine and the related words for relevant publications up to 24.3.2020. The present systematic review was performed based on PRISMA protocol. Data extraction and quality valuation of articles were performed by two reviewers. 51 articles were the results of the search and based on the inclusions and exclusions criteria, 7 articles were included in the final review. As a conclusion of these studies demonstratedthat although no serious research has been done on this subject at the time of writing this article, similar studies on the related viruses showed notable results. So immunotherapy for this virus can also be a suitable option. SN - 1878-1705 UR - https://www.unboundmedicine.com/medline/citation/32272396/The_possible_of_immunotherapy_for_COVID_19:_A_systematic_review_ DB - PRIME DP - Unbound Medicine ER -